Stock Markets February 9, 2026

Premarket Movers: Novo Nordisk, Kroger and Eli Lilly Lead Gains While Micron Slips

U.S. futures edge down as investors parse earnings, regulatory actions and sector-specific developments

By Nina Shah NVO HIMS KR DT
Premarket Movers: Novo Nordisk, Kroger and Eli Lilly Lead Gains While Micron Slips
NVO HIMS KR DT

U.S. stock futures edged lower Monday as markets brace for a week that will bring key economic data and additional corporate earnings. Several individual stocks moved sharply in premarket trading: Novo Nordisk, Kroger and Eli Lilly advanced, while Hims Hers Health, Micron Technology and others declined on company-specific news and sector pressures.

Key Points

  • Healthcare names led premarket gains and losses as regulatory and legal actions influenced share prices - impacts on telehealth and pharmaceutical stocks were notable.
  • Tech and chipmakers saw divergent moves: an AI software beat lifted Dynatrace, while reports of Samsung ramping next-generation HBM production pressured Micron - semiconductor competition is a key driver.
  • Corporate leadership changes and M&A activity moved individual stocks, with Kroger's CEO selection and Eli Lilly’s proposed acquisition drawing investor attention.

U.S. stock futures were modestly lower on Monday as traders prepared for a week that includes important economic releases and additional corporate earnings reports. Market participants were focused on a slate of company-specific developments that produced notable premarket moves across healthcare, retail, semiconductors and financial services.


Major premarket movers

  • Novo Nordisk (NYSE:NVO) jumped 5.7% in premarket trading. The gain followed legal and regulatory pressure surrounding a newly launched competitor product - developments that prompted the rival telehealth company to withdraw its offering.

  • Hims Hers Health (NYSE:HIMS) plunged 20% after announcing it had pulled its newly launched $49 compounded weight-loss pill over the weekend. The company withdrew the product following pressure from both Novo Nordisk and the U.S. Food and Drug Administration.

  • Kroger (NYSE:KR) climbed 5.3% after a report said the grocery chain selected former Walmart executive Greg Foran as its chief executive, roughly a year after Rodney McMullen was ousted.

  • Dynatrace (NYSE:DT) surged 13% after the AI-focused software firm posted third-quarter fiscal 2026 results that beat expectations and raised its full-year guidance.

  • Micron Technology (NASDAQ:MU) retreated 2.9% after reports indicated Samsung Electronics will commence mass production of next-generation high-bandwidth memory chips this month, increasing competition in the high-bandwidth memory market.

  • Eli Lilly (NYSE:LLY) rose 1.8% after announcing plans to acquire therapy developer Orna Therapeutics for up to $2.4 billion in cash.

  • Apollo Global Management (NYSE:APO) increased 4.3% after reporting a 13% rise in fourth-quarter profit, driven by fresh client inflows and robust debt origination.

  • Cleveland-Cliffs (NYSE:CLF) dropped 3.7% despite reporting a narrower-than-expected fourth-quarter loss; the company's revenue missed analyst expectations amid weak automotive production.

  • STMicroelectronics (NYSE:STM) ADRs gained 6.5% after the chipmaker expanded a strategic partnership with Amazon Web Services, a move investors viewed as increasing the firm's exposure to data center and cloud infrastructure markets.

  • Nexxen (NASDAQ:NEXN) jumped 16% following a Sky News report that the advertising technology firm had attracted takeover interest.

  • Li Auto (NASDAQ:LI) fell 3.1% after JPMorgan downgraded the Chinese automaker to "underweight" from "neutral," citing expectations that new EV models from other carmakers will pressure Li Auto's sales this year.

  • SoFi Technologies (NASDAQ:SOFI) gained 3% after Citizens upgraded the online personal finance company to "market outperform" from "market perform," noting the stock had fallen about 20% year-to-date.


These moves reflect a mix of regulatory and competitive pressures, leadership changes, earnings beats and downgrades. The day’s activity highlighted how company-specific news can drive significant intraday volatility even as broader market indicators remain subdued.

Investors continue to weigh upcoming macroeconomic releases and more corporate results due later in the week as they reassess sector exposures and company valuations.

Risks

  • Regulatory and legal intervention - Hims Hers pulled its weight-loss pill following pressure from Novo Nordisk and the U.S. FDA, underscoring regulatory risk in healthcare and telehealth sectors.
  • Intensified competition in semiconductor memory - reports that Samsung will mass produce next-generation high-bandwidth memory chips could heighten market competition and pressure margins for memory chip makers.
  • Weak automotive production - Cleveland-Cliffs reported revenue below expectations amid weak auto production, highlighting demand-side risk for steelmakers and suppliers in the automotive supply chain.

More from Stock Markets

Samsung Shares Surge to Record on Report It Could Be Nvidia's Exclusive HBM4 Supplier Feb 22, 2026 Microsoft gaming leadership reshuffled as Phil Spencer retires and Asha Sharma named CEO Feb 22, 2026 U.S. Futures Slide as Trump Moves to Reapply Tariffs Under Alternate Law; Nvidia Results in Focus Feb 22, 2026 Asia Markets Wary as U.S. Tariff Uncertainty and Nvidia Results Loom Feb 22, 2026 Rolls-Royce Set to Reveal Up to £1.5 Billion Share Buyback Alongside Annual Results Feb 22, 2026